latest development

London (UK), Rehovot (Israel) August 11th, 2023
Vidac Pharma Holdings Plc. (SYM: T9G; ISIN: GB00BM9XQ619; WKN: A3DTUQ).

London August 11. Vidac Pharma Holding Plc announced that from today August 11, its shares will be dual listed simultaneously on both the Hamburg and the Stuttgart stock
exchange to facilitate trading.
Stuttgart Börse Exchange benefits from continuous trading, a feature wished by many individuals and potential investors as well as by our present Shareholders.
“This is a very important step" commented Prof.Dr Max Herzberg, Chairman of the company, “as the progress of the Company in all fronts might attract more individual investors to accompany its developments. The trading in the Hamburg exchange taught us about the high interest of many to Vidac Pharma revolutionary approach to drug discovery and promising successes made in the Clinical trials results thus far”.

Rehovot (Israel), London (UK)

About Vidac Pharma: Vidac Pharma Holdings Plc. London, is the holding company of Vidac Pharma Ltd. Rehovot. The Company is a clinical stage biopharmaceutical company dedicated to discovering and developing First-in-class medicines to help people suffering from a range of oncologic and dermatologic diseases.

The following information does not constitute a public offer to sell or a solicitation to submit an offer to buy or subscribe to shares of Vidac Pharma Holding PLC, but is for informational purposes only.

Vidac Pharma Holding PLC
Dr. Max Herzberg
20-22 Wenlock Road
London N1 7GU
United Kingdom
+972 (0)779300647